Zimmer Biomet adjusts earnings guidance, shares anchored in NYSE medtech peer group

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-29, 09:09.

Zimmer Biomet (US98956P1021) reports a full-year 2026 earnings guidance range of 8.40 to 8.55 dollars per share, according to recent analyst coverage on the NYSE-listed medtech group. The company’s April quarterly release showed it beating consensus estimates on adjusted earnings per share.

What the latest figures show

Zimmer Biomet last posted quarterly results on Tuesday, April 28, reporting adjusted earnings per share of 2.09 dollars versus analyst expectations of 1.86 dollars, a 0.23 dollar positive surprise. The stock is traded on the NYSE under the ticker ZBH, anchoring it among large-cap U.S. medical equipment names.

Over the trailing twelve months, Zimmer Biomet shares have traded between a low of 79.12 dollars and a high of 108.29 dollars, giving investors a sense of the stock’s recent volatility band. At a recent market capitalization of around 17.98 billion dollars, the company sits in the mid- to large-cap bracket of the global medtech sector.

Balance sheet and valuation metrics

Analyst data cited by MarketBeat point to a quick ratio of 0.95 and a current ratio of 1.73 for Zimmer Biomet, indicating liquidity that covers short-term obligations reasonably well. A debt-to-equity ratio of 0.50 underscores a moderate use of leverage compared with some NYSE-listed peers.

The medical equipment provider is currently tracked with a price-to-earnings ratio of about 24.14 and a PEG ratio near 2.74, placing the valuation in a middle range relative to faster-growing medtech names such as Intuitive Surgical. A reported beta of 0.47 suggests Zimmer Biomet shares have historically shown lower volatility than the broader U.S. equity market.

The business behind the stock

Zimmer Biomet generates revenue primarily from orthopedic implants, joint replacement systems and related surgical products in hip, knee and shoulder reconstruction, along with trauma and spine solutions. The group also offers robotic and navigation technologies that complement implants in operating rooms worldwide.

Where the shares trade today

Zimmer Biomet shares (US98956P1021) most recently closed on the NYSE at 92.92 dollars on June 26, 2026, with after-hours trading at 93.09 dollars according to MarketBeat data. This price region places the stock roughly mid-way between its twelve-month high and low.

This article is for informational purposes only and does not constitute investment advice, a recommendation or an offer to buy or sell any securities. Data and figures are based on sources cited and may change over time.